CRISPR THERAPEUTICS AG (CRSP) /
The debt of CRISPR THERAPEUTICS AG over the past 10 years
Chart CRISPR THERAPEUTICS AG: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, CRISPR THERAPEUTICS AG had liquid cash of $1.98B and total debt of $0: net cash of $1.98B. It had more liquid cash than debt at all 10 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.98B* | $0 | $1.98B |
| 2024ended Dec 31, 2024 | $1.9B* | $0 | $1.9B |
| 2023ended Dec 31, 2023 | $1.69B* | $0 | $1.69B |
| 2022ended Dec 31, 2022 | $1.82B* | $0 | $1.82B |
| 2021ended Dec 31, 2021 | $2.38B* | $0 | $2.38B |
| 2020ended Dec 31, 2020 | $1.69B* | $0 | $1.69B |
| 2019ended Dec 31, 2019 | $943.77M* | $0 | $943.77M |
| 2018ended Dec 31, 2018 | $456.65M | $0 | $456.65M |
| 2017ended Dec 31, 2017 | $239.76M | $0 | $239.76M |
| 2016ended Dec 31, 2016 | $315.52M | $0 | $315.52M |
Fiscal years as CRISPR THERAPEUTICS AG reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CRISPR THERAPEUTICS AG
- The revenue of CRISPR THERAPEUTICS AG
- The profitability of CRISPR THERAPEUTICS AG
- The cash flow of CRISPR THERAPEUTICS AG
- All of CRISPR THERAPEUTICS AG's financials, charted
Companies of a similar size
- CUZCOUSINS PROPERTIES INC
- CIGIColliers International Group Inc.
- RYNRAYONIER INC.
- MATMATTEL INC /DE/
- NWENORTHWESTERN ENERGY GROUP, INC.
Not investment advice. This page shows what CRISPR THERAPEUTICS AG filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.